Amara Raja Shares Jump on EV Battery Tech Licensing Deal With China's Gotion
By Kosaku Narioka
Amara Raja Energy & Mobility shares rose sharply after its unit signed a licensing agreement with a subsidiary of China's Gotion High-Tech to produce lithium-ion batteries for electric vehicles in India.
Shares were recently 17% higher at 1,614.95 rupees in early afternoon trading Tuesday after rising as much as 20% earlier.
Amara Raja said after Monday's market close that the Gotion High-Tech unit will license its technology for lithium-ion cells to the Amara Raja subsidiary and that the partnership will accelerate its efforts in setting up a large-scale research and development and manufacturing site in the southern Indian state of Telangana.
Amara Raja has said it will invest INR95 billion ($1.14 billion) to establish the Telangana site to produce lithium-ion cells for EVs and other energy-storage use.
"We firmly believe that India will be one of the fastest growing EV markets," Amara Raja Chairman Jayadev Galla said, adding that the company's expertise in the energy and mobility space and Gotion's technology will be a winning combination.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
June 25, 2024 03:26 ET (07:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk